Covered recipient · General Payments record
AMBER ALONZO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$2,852.51
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $903.68 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $578.07 | 25 |
| Galderma Laboratories, L.P. | $193.05 | 6 |
| REVANCE THERAPEUTICS, INC. | $132.56 | 6 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.55 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431246 | CMS |
| ABBVIE INC. | $8.63 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431248 | CMS |
| ABBVIE INC. | $24.99 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431250 | CMS |
| ABBVIE INC. | $27.79 | 03/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431252 | CMS |
| ABBVIE INC. | $25.25 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431254 | CMS |
| ABBVIE INC. | $29.47 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431256 | CMS |
| ABBVIE INC. | $25.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431258 | CMS |
| ABBVIE INC. | $27.10 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431260 | CMS |
| ABBVIE INC. | $26.93 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431262 | CMS |
| ABBVIE INC. | $14.90 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431264 | CMS |
| ABBVIE INC. | $27.19 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431266 | CMS |
| ABBVIE INC. | $8.75 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431268 | CMS |
| ABBVIE INC. | $18.65 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431270 | CMS |
| ABBVIE INC. | $52.22 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431272 | CMS |
| ABBVIE INC. | $37.31 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431274 | CMS |
| ABBVIE INC. | $22.03 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431276 | CMS |
| ABBVIE INC. | $12.01 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431278 | CMS |
| ABBVIE INC. | $26.56 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431280 | CMS |
| ABBVIE INC. | $22.64 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431282 | CMS |
| ABBVIE INC. | $21.05 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431284 | CMS |
| ABBVIE INC. | $21.64 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431286 | CMS |
| ABBVIE INC. | $10.05 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431288 | CMS |
| ABBVIE INC. | $26.68 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431290 | CMS |
| ABBVIE INC. | $18.27 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431292 | CMS |
| ABBVIE INC. | $21.14 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106431294 | CMS |
| Galderma Laboratories, L.P. | $19.39 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338732 | CMS |
| Galderma Laboratories, L.P. | $5.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338734 | CMS |
| Galderma Laboratories, L.P. | $22.13 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338736 | CMS |
| Galderma Laboratories, L.P. | $15.95 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338738 | CMS |
| Galderma Laboratories, L.P. | $112.02 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338740 | CMS |
| Galderma Laboratories, L.P. | $18.06 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145338742 | CMS |
| REVANCE THERAPEUTICS, INC. | $29.67 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932986 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.37 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932988 | CMS |
| REVANCE THERAPEUTICS, INC. | $19.87 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932990 | CMS |
| REVANCE THERAPEUTICS, INC. | $24.98 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932992 | CMS |
| REVANCE THERAPEUTICS, INC. | $23.83 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932994 | CMS |
| REVANCE THERAPEUTICS, INC. | $8.84 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147932996 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.